Glucocorticoid activation by 11β-hydroxysteroid dehydrogenase enzymes in relation to inflammation and glycaemic control in chronic kidney disease: A cross-sectional study
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Glucocorticoid activation by 11β-hydroxysteroid dehydrogenase enzymes in relation to inflammation and glycaemic control in chronic kidney disease: A cross-sectional study
Authors
Keywords
-
Journal
CLINICAL ENDOCRINOLOGY
Volume 90, Issue 1, Pages 241-249
Publisher
Wiley
Online
2018-10-26
DOI
10.1111/cen.13889
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Effects of intensive glucose control on microvascular outcomes in patients with type 2 diabetes: a meta-analysis of individual participant data from randomised controlled trials
- (2017) Sophia Zoungas et al. Lancet Diabetes & Endocrinology
- Changes in gluconeogenesis and intracellular lipid accumulation characterize uremic human hepatocytes ex vivo
- (2016) Meng Li et al. AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY
- Genetic Variation in the 11β-hydroxysteroid-dehydrogenase 1 Gene Determines NAFLD and Visceral Obesity
- (2016) Stefan Z. Lutz et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- 11β-Hydroxysteroid dehydrogenase type 1 within muscle protects against the adverse effects of local inflammation
- (2016) Rowan S Hardy et al. JOURNAL OF PATHOLOGY
- Comorbidities in Cushing’s disease
- (2015) S. T. Sharma et al. Pituitary
- Differential glucocorticoid metabolism in patients with persistent versus resolving inflammatory arthritis
- (2015) Dominika E Nanus et al. ARTHRITIS RESEARCH & THERAPY
- TNFα regulates cortisol metabolism in vivo in patients with inflammatory arthritis
- (2014) Dominika E Nanus et al. ANNALS OF THE RHEUMATIC DISEASES
- Tissue-specific dysregulation of 11β-hydroxysteroid dehydrogenase type 1 in overweight/obese women with polycystic ovary syndrome compared with weight-matched controls
- (2014) Alessandra Gambineri et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Elevated hepatic 11 -hydroxysteroid dehydrogenase type 1 induces insulin resistance in uremia
- (2014) A. Chapagain et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- 11 -HSD1 is the major regulator of the tissue-specific effects of circulating glucocorticoid excess
- (2014) S. A. Morgan et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Kidney Disease and Increased Mortality Risk in Type 2 Diabetes
- (2013) M. Afkarian et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- 11β-Hydroxysteroid Dehydrogenases: Intracellular Gate-Keepers of Tissue Glucocorticoid Action
- (2013) Karen Chapman et al. PHYSIOLOGICAL REVIEWS
- The natural history of, and risk factors for, progressive Chronic Kidney Disease (CKD): the Renal Impairment in Secondary care (RIISC) study; rationale and protocol
- (2013) Stephanie Stringer et al. BMC Nephrology
- Inflammatory regulation of glucocorticoid metabolism in mesenchymal stromal cells
- (2012) Mohammad M. Ahasan et al. ARTHRITIS AND RHEUMATISM
- Chronic Kidney Disease, Insulin Resistance, and Incident Diabetes in Older Adults
- (2012) H. Pham et al. Clinical Journal of the American Society of Nephrology
- Association between Albuminuria, Kidney Function, and Inflammatory Biomarker Profile in CKD in CRIC
- (2012) J. Gupta et al. Clinical Journal of the American Society of Nephrology
- Insulin Resistance in Patients with Chronic Kidney Disease
- (2012) Min-Tser Liao et al. JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY
- Role of 11βHSD Type 2 Enzyme Activity in Essential Hypertension and Children with Chronic Kidney Disease (CKD)
- (2012) Anil Mongia et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Can 11β-Hydroxysteroid Dehydrogenase Activity Predict the Sensitivity of Bone to Therapeutic Glucocorticoids in Inflammatory Bowel Disease?
- (2011) Mark S. Cooper et al. CALCIFIED TISSUE INTERNATIONAL
- Effects of an 11β-hydroxysteroid dehydrogenase type 1 inhibitor, MK-0916, in patients with type 2 diabetes mellitus and metabolic syndrome
- (2011) P. U. Feig et al. DIABETES OBESITY & METABOLISM
- Urine Steroid Metabolomics as a Biomarker Tool for Detecting Malignancy in Adrenal Tumors
- (2011) Wiebke Arlt et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Cortisone-reductase deficiency associated with heterozygous mutations in 11 -hydroxysteroid dehydrogenase type 1
- (2011) A. J. Lawson et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The effect of spironolactone upon corticosteroid hormone metabolism in patients with early stage chronic kidney disease
- (2010) Fabian Hammer et al. CLINICAL ENDOCRINOLOGY
- The 11- -Hydroxysteroid Dehydrogenase Type 1 Inhibitor INCB13739 Improves Hyperglycemia in Patients With Type 2 Diabetes Inadequately Controlled by Metformin Monotherapy
- (2010) J. Rosenstock et al. DIABETES CARE
- 11 -Hydroxysteroid Dehydrogenase Type 1 Regulates Glucocorticoid-Induced Insulin Resistance in Skeletal Muscle
- (2009) S. A. Morgan et al. DIABETES
- Age-dependent Decrease in 11 -Hydroxysteroid Dehydrogenase Type 2 (11 -HSD2) Activity in Hypertensive Patients
- (2008) J. Henschkowski et al. AMERICAN JOURNAL OF HYPERTENSION
- Expression profiles of human 11β-hydroxysteroid dehydrogenases type 1 and type 2 in inflammatory bowel diseases
- (2008) J.P. Stegk et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
- Modulation of 11β-Hydroxysteroid Dehydrogenase (11βHSD) Activity Biomarkers and Pharmacokinetics of PF-00915275, a Selective 11βHSD1 Inhibitor
- (2007) Rachel Courtney et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Inflammation and Insulin Resistance in Uremia
- (2007) Michela Zanetti et al. JOURNAL OF RENAL NUTRITION
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started